Not provided
Not provided
Not provided
Not provided
Not provided
Study terminated due to lack of enrollment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Vistakon Pharmaceuticals | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing penetrating keratoplasty (PK)
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental |
| |
| 2 | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 1.5% levofloxacin ophthalmic solution | Drug | Topical application Instill 1 drop two times, 5 minutes apart. Time from last drop to surgery is determined by group. Group 1: 30 minutes prior to surgery Group 2: 1 hour prior to surgery Group 3: 2 hours prior to surgery Group 4: 4 hours prior to surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Concentration of levofloxacin and moxifloxacin in the corneal tissue | Time of surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Adverse Events | 4 days |
Not provided
Inclusion Criteria
Exclusion Criteria
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Boynton Beach | Florida | United States | ||||
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| 0.5% moxifloxacin ophthalmic solution | Drug | Topical application Instill 1 drop two times, 5 minutes apart. Time from last drop to surgery is determined by group. Group 5: 30 minutes prior to surgery Group 6: 1 hour prior to surgery Group 7: 2 hours prior to surgery Group 8: 4 hours prior to surgery |
|
|
| Indianapolis |
| Indiana |
| United States |
| Great Rapids | Michigan | United States |
| Kansas City | Missouri | United States |
| Springfield | Missouri | United States |
| Stony Brook | New York | United States |
| Cincinnati | Ohio | United States |
| Portland | Oregon | United States |
| ID | Term |
|---|---|
| D000077266 | Moxifloxacin |
| ID | Term |
|---|---|
| D024841 | Fluoroquinolones |
| D042462 | 4-Quinolones |
| D015363 | Quinolones |
| D011804 | Quinolines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided